New Study to Get More Minorities Involved in Genetic Testing
978 articles
Phase II/III Clinical Trial Recruiting Advanced Pancreatic Cancer Patients
Dr. Shalini Makawita is a primary investigator in a phase IIb/III immunotherapy clinical trial for advanced pancreatic cancer patients.
Comprehensive Molecular Test Helps Classify Pancreatic Cysts
Dr. Aatur Singhi and colleagues are developing a test to help determine whether pancreatic cysts are likely to turn cancerous.
Targeting Pancreatic Cancer Cell Growth
Researchers are testing a new drug targeting cell growth in solid tumors, including pancreatic cancer.
A Report from ASCO GI 2022
Clinical trials were reported on at ASCO GI 2022, as well as reports on COVID, virtual tumor boards, and racial disparities in treatment.
Blood-Based Test Predicts What Drugs May Work Best
Dr. Kenneth Yu is testing a blood-based assay that looks at which types of chemotherapies will work best for each pancreatic cancer patient.
Machine-Learning Assay May Improve Pancreatic Cyst Management
Dr. Anne Marie Lennon explains CompCyst, the artificial intelligence-based assay that can determine the best treatment for pancreatic cysts.
Chemotherapy Plus Immunotherapy Trial Shows Promise
Dr. Gulam Manji leads a clinical trial that uses two types of immunotherapy to enhance chemotherapy for pancreatic cancer patients.
Potential Therapy Takes a Two-Prong Attack on Pancreatic Cancer
With a focus on targeting cell metabolism, Dr. Anup Kasi leads a clinical trial of a new agent in combination with gemcitabine.